-
Presenter Profile: Practical Obesity Management in the Primary Care Setting
Justina Adangai, FNP-C, BC-ADM, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 8:00 a.m. CT.
-
Presenter Profile: Humoral Interoception: Leptin Circuits and Energy Homeostasis
Heike Münzberg, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 4:30 p.m. CT.
-
Presenter Profile: Age-Related Adipose Remodeling and Metabolic Dysfunction
Qiong Annabel Wang, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person 12:00 a.m., at 8:00 a.m. CT.
-
Presenter Profile: Sexual Dimorphism in the Setting of Type 1 Diabetes
Raghavendra Mirmira, MD, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 6, at Saturday, December 30 CT.
-
Presenter Profile: Systemic Effects of Liver Senescence in Relation to Metabolic Disease
Kuo Du, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 6, at 8:00 a.m. CT.
-
Presenter Profile: Roots of Inequity: In Utero Social and Environmental Impacts on Childhood Metabolic Risk
Izzuddin Aris, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 8:00 a.m. CT.
-
Presenter Profile: The Mitochondrial Pyruvate Carrier Governs Skeletal Muscle Metabolic Flexibility
Katsu Funai, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Monday, June 8, at 8:00 a.m. CT.
-
Presenter Profile: Sexual Dimorphism in β-Cell Physiology and Susceptibility to Dysfunction
Emilyn Alejandro, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 6, at 8:00 a.m. CT.
-
Investigators to bring data on glucose management with oral orforglipron
Julio Rosenstock, MD, Francesco Giorgino, MD, PhD, and other panelists will discuss results from the ACHIEVE clinical trials, including ACHIEVE-3, which compared oral semaglutide and orforglipron for use in type 2 diabetes.
-
Researchers to share VESPER phase 2 clinical trial data
Investigators, including John B. Buse, MD, PhD, will discuss new insights from the VESPER program examining berobenatide, an ultra-long-acting glucagon-like peptide-1 (GLP-1) receptor agonist for weight management.